Article Details
Retrieved on: 2024-10-24 15:56:17
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses a monoclonal antibody therapy developed at UCLA, targeting ENPP1 to enhance heart tissue repair post-heart attack, aligning with the regenerative medicine concept and involving biotechnology, immunology, and tissue engineering.
Article found on: newsroom.ucla.edu
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here